Market Insights Health Pharmacies OTC Products

Wound Care (Pharmacies) - Serbia

Serbia

Revenue in the Wound Care market is projected to reach US$1.53m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.27%, resulting in a market volume of US$1.63m by 2029.
In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
In relation to total population figures, per person revenues of US$0.21 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

Market

Region

Region comparison

Currency

Analyst Opinion

The Wound Care (Pharmacies) market in Serbia is experiencing steady growth due to various factors such as increasing customer preferences for convenience and accessibility, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Serbia are increasingly seeking convenience and accessibility when it comes to wound care products. They prefer to purchase these products from pharmacies, as they offer a wide range of options and professional advice. Pharmacies are also easily accessible to customers, with many located in residential areas and open for extended hours. This preference for convenience and accessibility is driving the growth of the Wound Care (Pharmacies) market in Serbia.

Trends in the market: One of the emerging trends in the Wound Care (Pharmacies) market in Serbia is the increasing demand for advanced wound care products. Customers are becoming more aware of the benefits of these products, which include faster healing, reduced scarring, and improved overall wound care. As a result, pharmacies are expanding their product offerings to include a wider range of advanced wound care products, such as hydrocolloid dressings, foam dressings, and antimicrobial dressings. This trend is driving the growth of the market as customers are willing to pay a premium for these advanced products.

Local special circumstances: Serbia has a high prevalence of chronic wounds, such as pressure ulcers and diabetic foot ulcers, which require specialized wound care products. This has created a significant demand for wound care products in the country. Additionally, the aging population in Serbia is also contributing to the growth of the market, as older individuals are more prone to wounds and require specialized wound care products. These local special circumstances are driving the growth of the Wound Care (Pharmacies) market in Serbia.

Underlying macroeconomic factors: The Serbian economy has been steadily growing in recent years, which has led to an increase in disposable income and consumer spending. This economic growth has positively impacted the Wound Care (Pharmacies) market, as customers have more purchasing power to invest in wound care products. Additionally, the government in Serbia has been focusing on improving healthcare infrastructure and services, which has further contributed to the growth of the market. These underlying macroeconomic factors are creating a favorable environment for the Wound Care (Pharmacies) market in Serbia. In conclusion, the Wound Care (Pharmacies) market in Serbia is experiencing steady growth due to increasing customer preferences for convenience and accessibility, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. As customers seek convenience and accessibility, pharmacies are expanding their product offerings to include advanced wound care products. The high prevalence of chronic wounds and the aging population in Serbia are also driving the growth of the market. Additionally, the growing economy and government focus on healthcare infrastructure are creating a favorable environment for the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.